Antipsychotics: impact on prolactin levels (Q34974785)

5 August 2017

1 reference

title

Antipsychotics: impact on prolactin levels (English)

1 reference

5 August 2017

3

Orlando Santana

1 reference

5 August 2017

Paul J Goodnick

1

1 reference

PubMed ID

12387684

5 August 2017

Lucero Rodriguez

series ordinal

2

1 reference

PubMed ID

12387684

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Expert Opinion on Pharmacotherapy

5 August 2017

1 reference

5 August 2017

3

1 reference

5 August 2017

10

1 reference

5 August 2017

1381-1391

1 reference

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

5 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Prolactin secretion in response to haloperidol challenge in delusional (psychotic) and non-delusional depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Relationships between psychotropic drug dosage, plasma drug concentration, and prolactin levels in nursing home residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Elevation of prolactin levels by atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Comparison of clozapine and haloperidol on some autonomic and psychomotor functions, and on serum prolactin concentration, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Prolactin levels and adverse events in patients treated with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.10.1381

10.1517/14656566.3.10.1381

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12387684